These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 25929853)

  • 41. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.
    Caraballo PJ; Bielinski SJ; St Sauver JL; Weinshilboum RM
    Clin Pharmacol Ther; 2017 Aug; 102(2):254-264. PubMed ID: 28390138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers and personalized therapy in chronic kidney diseases.
    Schena FP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1051-4. PubMed ID: 24857812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Big data in pharmacogenomics: current applications, perspectives and pitfalls.
    Barrot CC; Woillard JB; Picard N
    Pharmacogenomics; 2019 Jun; 20(8):609-620. PubMed ID: 31190620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Personalized Medicine: A big promise for the future].
    Ertl G
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1483-4. PubMed ID: 26445248
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacogenomics: paving the path to personalized medicine.
    Patrinos GP; Innocenti F
    Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
    Blix A
    Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beyond genomics: understanding exposotypes through metabolomics.
    Rattray NJW; Deziel NC; Wallach JD; Khan SA; Vasiliou V; Ioannidis JPA; Johnson CH
    Hum Genomics; 2018 Jan; 12(1):4. PubMed ID: 29373992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
    Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
    Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Application of pharmacogenomics and other new technologies to drug development].
    Cabaleiro T; Prieto-Pérez R; Ochoa D; Abad-Santos F
    Med Clin (Barc); 2013 Jun; 140(12):558-63. PubMed ID: 23582104
    [No Abstract]   [Full Text] [Related]  

  • 52. Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine.
    Ramsey LB; Prows CA; Zhang K; Saldaña SN; Sorter MT; Pestian JP; Wenstrup RJ; Vinks AA; Glauser TA
    Clin Pharmacol Ther; 2019 Jan; 105(1):49-52. PubMed ID: 30058217
    [No Abstract]   [Full Text] [Related]  

  • 53. [PHARMACOGENOMICS AND PERSONALIZED MEDICINE: TOWARDS A SYSTEMATIC GENOMIC SCREENING?].
    Dideberg V; Segers K; Koopmansch B; Lambert F; Bours V
    Rev Med Liege; 2015; 70(5-6):251-6. PubMed ID: 26285448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
    Sanoudou D
    Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
    [No Abstract]   [Full Text] [Related]  

  • 55. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenomics in the clinic.
    Relling MV; Evans WE
    Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Personalized medicine and individual healthcare : Medical and information technology aspects].
    Niederlag W; Lemke HU; Rienhoff O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):776-82. PubMed ID: 20700776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
    Johnson JA; Weitzel KW
    Clin Pharmacol Ther; 2016 Feb; 99(2):154-6. PubMed ID: 26440500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolomics as a tool for drug discovery and personalised medicine. A review.
    Mastrangelo A; Armitage EG; García A; Barbas C
    Curr Top Med Chem; 2014; 14(23):2627-36. PubMed ID: 25515755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.